Other languages Journey Medical Corporation

Equities

DERM

US48115J1097

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-01 EDT			5-day change	1st Jan Change
3.51 ^USD	-4.88%		+3.24%	-39.06%

03-21	Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024
03-21	Journey Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Journey Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-21
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	03-18
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 on Microbial Flora of Healthy Adults At 2024 Annual Meeting	03-11
Journey Medical Submits New Drug Application to FDA for Rosacea Treatment; Shares Rise	01-05
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea	01-05
Journey Medical Signs Credit Facility of up to $20 Million	01-02
Journey Medical Corporation Announces Resignation of Jeffrey Paley as Member of the Board of Directors	12-08
Journey Medical Corporation Announces Successful Completion of Pre-Nda Meeting with the Fda for Dfd-29 to Treat Rosacea	12-06
Journey Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07
Journey Medical Says Study Shows Bioavailability of Minocycline Lower After One Dose of DFD-29 Compared With Solodyn	23-10-20
Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29	23-10-20
Insider Buy: Journey Medical	23-09-08
Journey Medical Grants Exclusive License to Maruho for Manufacturing, Commercialization of Qbrexza in Asia	23-09-06
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza in South Korea and Other Asian Nations	23-09-06
Journey Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Sector Update: Health Care Stocks Declining Monday Afternoon	23-07-03
Sector Update: Health Care	23-07-03
Journey Medical to Release Topline Results from Two Phase 3 Studies on DFD-29 Next Week; Shares Climb	23-07-03
Sector Update: Health Care Stocks Higher Late Tuesday	23-06-13
Sector Update: Health Care Stocks Advancing in Tuesday Afternoon Trading	23-06-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Journey Medical Corporation

Equities

DERM

US48115J1097

Other languages

Filters